Advisornet Financial’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Advisornet Financial’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$142K	Sell	4,201 -720	-15%	-$24K	0.01%	749
2026 Q1	$148K	Sell	4,921 -69	-1%	-$2.22K	0.01%	693
2025 Q4	$156K	Hold	4,990	–	–	0.01%	673
2025 Q3	$101K	Hold	4,990	–	–	0.01%	787
2025 Q2	$83.6K	Buy	4,990 +513	+11%	+$8.28K	0.01%	810
2025 Q1	$68.8K	Hold	4,477	–	–	0.01%	830
2024 Q4	$98.7K	Sell	4,477 -200	-4%	-$3.64K	0.01%	694
2024 Q3	$84.3K	Sell	4,677 -1,000	-18%	-$17.5K	0.01%	743
2024 Q2	$92.3K	Hold	5,677	–	–	0.01%	666
2024 Q1	$80.1K	Hold	5,677	–	–	0.01%	692
2023 Q4	$59.3K	Sell	5,677 -2,431	-30%	-$22.7K	0.01%	764
2023 Q3	$82.7K	Buy	8,108 +4,500	+125%	+$41.9K	0.01%	662
2023 Q2	$27.2K	Buy	3,608 +660	+22%	+$5.35K	﹤0.01%	987
2023 Q1	$26.1K	Hold	2,948	–	–	﹤0.01%	983
2022 Q4	$26.9K	Hold	2,948	–	–	﹤0.01%	964
2022 Q3	$24K	Buy	2,948 +1,458	+98%	+$12.9K	﹤0.01%	1058
2022 Q2	$11K	Buy	1,490 +1,413	+1,835%	+$12.3K	﹤0.01%	1320
2022 Q1	$1K	Hold	77	–	–	﹤0.01%	1934
2021 Q4	$1K	Buy	77 +73	+1,825%	+$659	﹤0.01%	1967
2021 Q3	$0	Hold	4	–	–	﹤0.01%	1997
2021 Q2	$0	Hold	4	–	–	﹤0.01%	1862
2021 Q1	$0	Sell	4 -350	-99%	-$4.01K	﹤0.01%	1827
2020 Q4	$3K	Hold	354	–	–	﹤0.01%	1520
2020 Q3	$3K	Buy	354 +205	+138%	+$2.17K	﹤0.01%	1519
2020 Q2	$2K	Hold	149	–	–	﹤0.01%	1618
2020 Q1	$1K	Sell	149 -500	-77%	-$5.12K	﹤0.01%	1717
2019 Q4	$6K	Sell	649 -3,016	-82%	-$26.9K	﹤0.01%	1509
2019 Q3	$25K	Buy	3,665 +1,525	+71%	+$11.7K	﹤0.01%	1129
2019 Q2	$20K	Hold	2,140	–	–	﹤0.01%	1052
2019 Q1	$34K	Sell	2,140 -50	-2%	-$882	﹤0.01%	846
2018 Q4	$34K	Sell	2,190 -450	-17%	-$9.22K	﹤0.01%	779
2018 Q3	$57K	Hold	2,640	–	–	0.01%	689
2018 Q2	$64K	Hold	2,640	–	–	0.01%	651
2018 Q1	$45K	Sell	2,640 -438	-14%	-$8.55K	0.01%	723
2017 Q4	$58K	Buy	+3,078	New	+$46.3K	0.01%	613

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Advisornet Financial's TEVA Position: Q2 2026 in Review

Advisornet Financial reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 15% in Q2 2026, selling an estimated $24K and leaving 4,201 shares worth $142K. The position accounts for 0.01% of the portfolio, ranked #749.

Advisornet Financial first reported a position in TEVA in Q4 2017 and has held it in 35 quarters since. The position peaked at $156K in Q4 2025. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Advisornet Financial held 4,201 shares of Teva Pharmaceutical Industries Limited worth $142K as of Q2 2026.
Advisornet Financial sold 720 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $24K.
Teva Pharmaceutical Industries Limited made up 0.01% of Advisornet Financial's portfolio in Q2 2026, its #749 holding.
Advisornet Financial first reported a position in Teva Pharmaceutical Industries Limited in Q4 2017 and has held it in 35 quarters since.
Advisornet Financial's Teva Pharmaceutical Industries Limited position peaked at $156K in Q4 2025.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.